Talecris prices IPO

Talecris Biotherapeutics Inc. (NASDAQ:TLCR) raised $550 million through the sale of 28.9

Read the full 128 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE